The Gross Law Firm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WISH, FREQ and RLX
NEW YORK, NY / ACCESSWIRE / July 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Contextlogic Inc. (NASDAQ:WISH)
This lawsuit is on behalf of: i) all persons or entities who purchased or otherwise acquired securities of ContextLogic, Inc. ("ContextLogic") (NASDAQ: WISH) and/or sold put options of ContextLogic during the period from December 16, 2020 to May 12, 2021, inclusive; and/or (ii) all persons who purchased ContextLogic securities pursuant and/or traceable to the Company's initial public offering conducted on or about December 16, 2020.
A class action has commenced on behalf of certain shareholders in Contextlogic Inc. In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic's business operations and financial prospects by overstating its then-present monthly active users ("MAUs") and MAU growth trends.
Shareholders may find more information at https://securitiesclasslaw.com/securities/contextlogic-inc-loss-submission-form/?id=17691&from=1
Frequency Therapeutics, Inc. (NASDAQ:FREQ)
Investors Affected: November 16, 2020 - March 22, 2021
A class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.
Shareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17691&from=1
RLX Technology Inc. (NYSE:RLX)
This lawsuit is on behalf of persons who purchased, or otherwise acquired, RLX American Depository Shares pursuant or traceable to the documents issued in connection with RLX's January 2021 initial public stock offering.
A class action has commenced on behalf of certain shareholders in RLX Technology Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's then-existing exposure to China's ongoing campaign to establish a national standard for e-cigarettes, which would bring them into line with ordinary cigarette regulations, and that RLX's reported financials were not nearly as robust as the offering materials projected, nor were they indicative of future results. As a result, investors purchased RLX shares at artificially inflated prices.
Shareholders may find more information at https://securitiesclasslaw.com/securities/rlx-technology-inc-loss-submission-form/?id=17691&from=1To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Fuego Enterprises, Inc.4.8.2021 21:01:46 CEST | Press release
Fuego Enterprises, Inc. Reports it has Received a License to Operate as a U.S. Business in the Republic of Cuba
Gungnir Resources Inc.4.8.2021 17:09:45 CEST | Press release
Gungnir Announces Private Placement
FinCanna Capital Corp.4.8.2021 16:25:41 CEST | Press release
FinCanna Portfolio Company, QVI Inc., Signs Strategic Agreement with Sense Distribution to Expand Retail Reach for Brand Clients Throughout California
CordovaCann Corp.4.8.2021 15:43:38 CEST | Press release
CordovaCann (CSE: CDVA / OTCQB: LVRLF) Completes Sale-Leaseback and Finances Oregon Expansion
Petroteq Energy Inc4.8.2021 15:34:38 CEST | Press release
Petroteq Provides Update on Form 10-Q and New Subscription
Kalo Gold Holdings Corp.4.8.2021 15:07:36 CEST | Press release
Kalo Gold Appoints Paul Harbidge as Technical Advisor
Brigadier Gold Limited4.8.2021 15:03:06 CEST | Press release
Brigadier Makes New Precious Metal Rich, Copper Discovery in Previously Unexplored Area at Picachos
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom